Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
The Canadian Journal of Cardiology|May 7, 2013
Antiplatelet therapy and cardiac surgery: review of recent evidence and clinical implicationsDavid Fitchett, C David Mazer, John Eikelboom, et al.
The Canadian Journal of Cardiology|December 5, 2002
Preventing thrombosis: update of first-line therapy in the management of non-ST segment elevation acute coronary syndromesDavid Fitchett, Shaun G Goodman, Milan Gupta, et al.
Diabetologia|August 2, 2018
Empagliflozin is associated with improvements in liver enzymes potentially consistent with reductions in liver fat: results from randomised trials including the EMPA-REG OUTCOME® trialNaveed Sattar, David Fitchett, Stefan Hantel, et al.
Circulation|January 23, 2003
Randomized evaluation of the safety and efficacy of enoxaparin versus unfractionated heparin in high-risk patients with non-ST-segment elevation acute coronary syndromes receiving the glycoprotein IIb/IIIa inhibitor eptifibatideShaun G Goodman, David Fitchett, Paul W Armstrong, et al.
Pharmacoepidemiology and Drug Safety|September 14, 2004
Use of time-dependent measures to estimate benefits of beta-blockers after myocardial infarctionAdrian R Levy, Robyn M Tamblyn, Michal Abrahamowicz, et al.
Annals of Epidemiology|March 7, 2002
The effect of physicians' training on prescribing beta-blockers for secondary prevention of myocardial infarction in the elderlyAdrian R Levy, Robyn M Tamblyn, Peter J Mcleod, et al.
International Journal of Cardiovascular Interventions|December 10, 2002
DNA integrity and transgene expression after passage through the NOGA needle catheter used for therapeutic myocardial angiogenesisMichael A Kuliszewski, Michael JB Kutryk, Reena Sandhu, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 23, 2009
The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysisSophie A Jamal, David Fitchett, Charmaine E Lok, et al.
Current Opinion in Cardiology|November 29, 2013
Prevention of thromboembolism in the patient with acute coronary syndrome and atrial fibrillation: the clinical dilemma of triple therapyDavid Fitchett, Atul Verma, John Eikelboom, et al.
The American Journal of Cardiology|January 16, 2007
Comparison of effectiveness of enoxaparin versus unfractionated heparin to reduce silent and clinically apparent acute myocardial infarction in patients presenting with non-ST-segment elevation acute coronary syndromeSanjit Jolly, Mary Tan, Aurora Mendelsohn, et al.
Pageof 10